Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Altimmune shares jumped 8.5% on Friday. The stock is higher ahead of next week's presentation at the European Association for ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

In patients with MASLD, precancerous lesions were positively associated with age and male gender, while negatively associated with advanced fibrosis.

Dr. Dyan Hes joined Fox 5 to share more on the connection between weight loss drugs and liver disease. Louis Serbeck, 54, ...

ACG released new guidance for the management of malnutrition in patients with liver disease, including the newly renamed ...